Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma is an effective and safe treatment for male pattern hair loss.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

Stem cells can effectively regrow hair in women with hair loss.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

Premature hair graying in young Turkish adults is more likely if they have stress, a family history of graying, drink alcohol, have chronic diseases, are older, or are taller.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Women with skin conditions who have body image concerns often experience mental health issues and a lower quality of life.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Murdha Taila, applied through the scalp, effectively treats head and neck issues and stimulates the nervous system.

Female androgenetic alopecia affects many women, is reversible with treatment like Minoxidil, and has significant psychological impacts.

Greater intimacy leads to better self-reported health in couples having infertility treatment.

Red clover extract improved hair, skin, mood, sleep, and tiredness in postmenopausal women.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Botanical treatments like saw palmetto, rosemary oil, and ginseng may help reduce hair loss in menopausal women.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

New 5% minoxidil solution improves scalp hydration, reduces redness, and may be safer for sensitive users.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Current treatments for severe alopecia areata are unsatisfactory, highlighting the need for better options.

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

Successful hair transplant surgery depends on careful patient selection, proper surgical plan and technique, and attentive aftercare.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

Dutasteride is more effective and better tolerated than finasteride for hair loss treatment.

Eyebrow hair transplants in patients with frontal fibrosing alopecia may look good at first but often lose the new hair after a few years.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.